Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP-1503 cream in atopic dermatitis (age ≥2 years)
CTR20231413Phase 3Completed
- Sponsor
- Zedman Pharma
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of TAP-1503 in atopic dermatitis (AD), sponsored by Zedman Pharma. Started May 2023; status: completed.
02
Drugs
TAP-1503
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on CTR20231413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231413.